ABC.L Regulatory News (ABC)

11 Jul 2007 07:00

ABCAM Plc11 July 2007 For immediate release 11 July 2007 ABCAM PLC ("Abcam" or "the Company") Change in role for Executive Director Cambridge UK: Abcam plc (AIM: ABC), the rapidly growing bioscience company thatmarkets antibodies via its own online catalogue, today announces that MarkWebster, Commercial Director, will resume his previous role as a Non-ExecutiveDirector on the Board of Abcam from 1st November. Commenting on today's announcement, David Cleevely, Abcam's Chairman, said: "I am pleased to say that Mark has achieved the objective we set out ofredefining and implementing our sales and marketing strategy particularly in theNorth American market. His work has already yielded good results for the Companyand we are looking forward to Mark continuing in his role as a Non-Executivemember of the Board of Abcam from the start of November." For further information please contact: Abcam + 44 (0) 1223 696000 Jonathan Milner, Chief Executive OfficerEddie Powell, Chief Financial Officer www.abcam.com Numis Securities + 44 (0) 20 7260 1000Michael Meade James Black Buchanan Communications + 44 (0) 20 7466 5000 Mark Court / Mary-Jane Johnson Notes for editors: About Abcam plc Abcam is a producer and distributor of research-grade antibodies headquarteredin Cambridge, UK, with a US office located in Cambridge, Massachusetts. Abcamwas admitted to AIM in November 2005 and trades under the ticker symbol ABC. TheCompany produces and distributes its own and third party produced antibodies toacademic and commercial users throughout the world with product informationprovided and ordering available through the Company's website, www.abcam.com.The antibodies are sold under the Abcam brand name. The Company's vision is tobuild the largest online antibody resource in the world while also ensuring thatthe antibodies are of high quality and commercially viable. Abcam now has anonline catalogue of approximately 33,000 products, most of which are antibodies,from over 200 suppliers supported by up-to-date and detailed technical datasheets, which are created by the Company. The Company currently employs 136staff in its three operating companies. This information is provided by RNS The company news service from the London Stock Exchange